Navigation Links
Freezing Kidney Cancer: Hot Treatment Should Be New Gold Standard for Destroying Small Tumors
Date:3/9/2009

at their cancer," noted Georgiades. When comparing the rate of complications between percutaneous cryoablation and surgery, Georgiades said that none of the patients who had cryoablation developed new or metastatic disease and they had fewer complications. The minimally invasive nature of interventional cryoablation means that it can be performed with minimal blood loss and without an incision, just a tiny hole in the skin. The interventional radiology treatment translates into significantly less pain, a shorter hospital stay and more rapid recovery. This safe treatment can be repeated, if necessary. The most common complication is a bruise around the kidney that goes away by itself, he said.

In studying cryoablation's efficacy, researchers looked at 90 tumors in 84 patients. Efficacy was determined based on a tumor's size at 3-, 6- and 12-month clinic visits and then yearly -- with follow-up imaging with CT or MRI scans. Both efficacy and three-year survival rates approach 100 percent overall.

In studying cryoablation's safety, Georgiades studied the results of 101 percutaneous cryoablations on 91 patients who either couldn't undergo surgery or elected the interventional radiology treatment. Using computed tomography (CT) imaging, researchers could view tumors and probes in real time. Interventional cryoablation "has an excellent safety profile," said Georgiades.

Cryoablation is typically performed under light anesthesia, known as sedation, by an interventional radiologist who has consulted with the patient's urologist. One or more hollow needles are inserted through the skin directly into a tumor. Interventional radiologists can observe and guide the insertion by combined use of ultrasound and CT. The needle, or cryoprobe, is filled with argon gas, which creates an ice ball, which rapidly freezes the tumor. The tumor is then thawed by replacing the argon with helium. The procedure consists of two freezing and on
'/>"/>

SOURCE Society of Interventional Radiology
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Bay Area Women Sought for Egg Freezing Study
2. Medgenics Announces Positive Data From Phase I/II Clinical Trial of EPODURE Treatment of Anemia in Chronic Kidney Disease
3. Latest RAD001 Study Results Show Further Increase in Time Without Tumor Growth in Patients With Advanced Kidney Cancer
4. VAI Findings Could Aid Diagnosis and Treatment of Several Types of Kidney Cancer
5. RAD001 Granted Priority Review in the US Based on Potential to Fill Unmet Medical Need in Patients With Advanced Kidney Cancer
6. Precise Low-Dose Drug Monitoring Essential for Long-Term Kidney Transplant Success
7. DaVita Strives to Improve Quality of Life and Reduce Overall Costs of Kidney Care Through Community-Based Education
8. CellCept(R) and a Reduced Level of CNI Shows Trend Towards Preservation of Kidney Function Versus a Standard-Dose CNI
9. University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients
10. New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer
11. Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... Aug. 27, 2015  The Academy of Managed ... Drug Administration,s (FDA,s) draft guidance and proposed rule ... biosimilars, to bear a nonproprietary name with an ... seeking a decision from the FDA on the ... care stakeholders urging the agency to use the ...
(Date:8/27/2015)... -- DURECT Corporation (Nasdaq: DRRX ) announced today ... healthcare conferences.  , James E. ... Rodman & Renshaw Investment Conference on Thursday, September 10 ... held at the St. Regis Hotel in ... of the presentation will be available by accessing ...
(Date:8/27/2015)... , Aug. 27, 2015 ieCrowd™ ... in the commercial development of the company,s supplemental ... Smart Oxygen device, being developed by ieCrowd,s subsidiary ... a patient,s changing demand for oxygen based on ... 510 (k) submission for the Smart Oxygen device ...
Breaking Medicine Technology:AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2DURECT to Participate in Upcoming Healthcare Conferences 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 4
... Watson Pharmaceuticals, Inc. (NYSE: WPI ... (FDA) approval of TRELSTAR® 22.5 mg (triptorelin pamoate for ... proven, simple and effective palliative treatment of advanced prostate ... is the first and only six-month intramuscular (IM) GnRH ...
... the bio-pharmaceutical industry, new product commercialization efforts have taken on increased importance. It,s against this backdrop that new product planning ... , ... , ... ...
Cached Medicine Technology:FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 2FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 3FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 4FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 5FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 6FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 7FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer 8Research from Best Practices, LLC Delivers Blueprint for Commercial Success of New Product Planning Groups 2Research from Best Practices, LLC Delivers Blueprint for Commercial Success of New Product Planning Groups 3Research from Best Practices, LLC Delivers Blueprint for Commercial Success of New Product Planning Groups 4
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... Juvent Sports ... growing list of major sports figures who are finding joint pain relief after using ... former #1 men’s tennis player in the world said, “For the first time in ...
(Date:8/31/2015)... ... August 31, 2015 , ... According to book reviewer ... Charge of Your Life with Cancer is an excellent resource for everyone since ... Cancer Solution to be helpful in explaining what cancer is in a easy to ...
(Date:8/31/2015)... , ... August 31, 2015 , ... Intellitec Solutions announced ... by bringing on board their 8th new staff member in 2015. With the potential ... the firm. Intellitec Solutions supports Microsoft Dynamics GP, Dynamics SL, Dynamics CRM and Intacct, ...
(Date:8/31/2015)... ... August 31, 2015 , ... healthbeautydistributors.com has been in ... test marketing a doctor note service to be made available to all patients ... for each generated excuse, much less than the average daily pay of workers. ...
(Date:8/30/2015)... ... 31, 2015 , ... Avid collector Andrew Hawley from Vintage Rock Posters announces ... This hand colored artwork is one of the most coveted Doors concert posters. The ... the doors played the Shrine, the band was one of the biggest bands ...
Breaking Medicine News(10 mins):Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 2Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 3Health News:New Book The Cancer Solution Is a Must Read for Everyone Affected by Cancer 2Health News:Intellitec Solutions Achieves Record Pace for New Hiring 2
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, ... activity, appears to be able to detect awareness in some ... new Canadian study finds. Functional MRI (fMRI) is also ... but the high cost and limited availability of these devices ...
... HealthDay Reporter , THURSDAY, Nov. 10 (HealthDay News) -- People ... restless legs syndrome, but many people with Parkinson,s do report ... new Norwegian study. People with restless legs ... legs. This typically occurs at night during rest, and the ...
... can lead to major health issues, including significant cognitive ... Departments of Neurology, Neurosurgery and Psychiatry at NYU Langone ... Nov. 10, 2011 issue of the New England ... sudden, unexpected death in epilepsy (SUDEP) and offers guidance ...
... This press release is available in German . ... mirror-inverted manner. They differ from each other like a left ... is referred to as chirality is of particular relevance to ... dioxide or methane are not chiral, many biologically relevant molecules, ...
... disease that many parents, even some doctors, mistake for ... diagnosed or treated in time, it can lead to ... genetic studies, scientists have been unable to pinpoint the ... an international team of scientists organized by Jane C. ...
... 2011)A new national initiative, IPAL-EM (Improving Palliative Care in ... palliative care when seriously ill patients are admitted to ... the role of the palliative care in emergency medicine, ... challenge of cultures and mindset. Supported by the ...
Cached Medicine News:Health News:Brain Study Suggests Some Vegetative Patients Are Aware 2Health News:Brain Study Suggests Some Vegetative Patients Are Aware 3Health News:Classic Restless Legs Syndrome Not Linked to Parkinson's 2Health News:NYU Langone expert calls for awareness, research of sudden death in patients with epilepsy 2Health News:Flexible rack systems sort molecules 2Health News:Kawasaki disease linked to wind currents 2Health News:Kawasaki disease linked to wind currents 3Health News:IPAL-EM launches to improve palliative care in emergency medicine 2
... 20 fume containment system work station ... swing-down front panel hinges from top ... opening. The sides and front ... is impervious to most chemicals. ...
... The STREP A OIA MAX test delivers ... Group A Strep with a simple, easy-to-use ... This combination of performance, speed, and ease-of-use ... while reducing overall costs for diagnosing and ...
... The FLU OIA A/B test combines performance equivalence ... of Influenza A or B with a simple, ... minutes. The test has all the same procedural ... test will enable you decrease costs for unnecessary ...
... The Acceava Mononucleosis test provides ... Mononucleosis with a simple procedure that ... Side-by-side evaluations with competitive products will ... These attributes enable you to deliver ...
Medicine Products: